Heterosubtypic immunity (HSI), defined as protective cross-reactivity to lethal infection with influenza A virus of a serotype different from the virus initially encountered, is thought to be mediated by cross-reactive cytotoxic T lymphocytes (CTL). This study provides direct evidence for the role of effector CTL versus B cells in HSI in mice with a targeted disruption in the a chain of CD8 molecule (CD8 + T cell deficient) or the immunoglobulin m heavy chain (B cell deficient), respectively. CD8 + T cell-deficient mice developed complete HSI. These mice displayed normal humoral immune responses, as determined by titers of subtype cross-reactive antibodies and virus-neutralizing antibodies specific for the immunizing influenza strain. In contrast, HSI was not observed in B cell-deficient mice, although these mice could mount cross-reactive CTL responses. These results show that B cells are required for HSI and provide new insight into the mechanisms of HSI, with significant implications in vaccine development.
cytotoxic activity to influenza virus-infected mice can reduce pulmonary virus titers, promote their recovery, and provide protection under certain circumstances [7] [8] [9] [10] [11] [12] [13] . We reported recently that subtype-specific CTL responses induced in mediastinal lymph nodes (MLNs), a mucosa-associated lymphoid tissue (MALT), are associated with host recovery after lethal infection with heterosubtypic influenza A virus [14] . In contrast, immunization with recombinant vaccinia virus expressing an NP epitope recognized by CD8 ϩ T cells readily induced primary pulmonary NP-specific CD8 ϩ CTL; however, no protection by these T cells upon challenge with virus was observed, as determined by virus titers, clearance kinetics, or survival [15] . In vivo depletion of CD8 ϩ T cells by monoclonal antibodies (MAbs) led to partial, but not complete, reduction of HSI [16] ), and HSI was also observed in b 2 -microglobulin-deficient [17] [18] [19] , T cell-depleted [19] , or interferon (IFN)-g-deficient mice [20] . Thus, the role of CD8 ϩ CTL as an effector mechanism for HSI remains controversial. Of note, adoptive transfer usually requires enormous numbers (e.g., 10 7 cells/mouse) of in vitro-cloned virus-specific CD8 ϩ CTL to achieve protection against heterosubtypic challenge, which raises questions about the effectiveness of virus-specific CD8 ϩ CTL responses for heterosubtypic protection.
The role of B cells in influenza virus infection has been studied mainly in primary influenza infection, where B cells appear to be of equal importance to CD8 ϩ T cells for recovery (reviewed in [21] ). Lack of B cells increased susceptibility to primary infection and secondary challenge with a homologous virus strain [22, 23] . However, HSI in the absence of B cells has not been adequately studied. Although HSI occurs in the absence of virus-specific antibodies that recognize predominantly the outer membrane proteins [2] , HSI is mediated in part by cross-reactive antibodies [24] . In addition, antibodies specific for internal viral proteins expressed on the surface of infected cells reduce the production of progeny virus and inhibit the spread of primary infection in SCID mice [25] .
Although recovery from primary virus infection involves both innate and acquired immunity, the latter is the major component for HSI, since it requires memory responses. Prominent candidate effectors for HSI are memory B cells and subtype-specific CD8 ϩ CTL. However, the effectiveness of these 2 effector cell types for complete HSI varies in different studies because of the dissimilar experimental designs. In this study, we used mice with targeted disruptions in the m chain (B cell deficient) [26] or in the a chain of the CD8 molecule (CD8 ϩ T cell deficient) [27] to provide direct evidence for the role of B cells and CD8
ϩ CTL, respectively, in HSI against lethal influenza A infection. ) mice were purchased at age 6-8 weeks (Jackson Laboratory). All mice were maintained under pathogen-free conditions in a flexible Trexler isolator (Standard Safety Equipment) and were given sterile food and water ad libitum. When used in the experiments, the mice were 8-10 weeks old.
Materials and Methods

Viruses
Immunization and challenge of mice. For immunization via total respiratory tract (TRT), ketamine-anesthetized mice were inoculated intranasally with a sublethal dose of pfu of A/ were maintained in standard complete medium (RPMI 1640; Gibco) containing 10% fetal bovine serum (FBS) and antibiotics.
Lung extraction for cytokine analysis. Extracts were prepared [28] from intact lungs for the assessment of cytokines characteristic of Th1 and Th2 responses. Before lung removal, the pulmonary vasculature was perfused with 1 mL of PBS containing 5 mM EDTA via the right heart ventricle. After removal, whole lungs were homogenized (Biospec Products tissue homogenizer) in 3 mL of lysis buffer containing 0.5% Triton X-100, 150 mM Tris, 1 mM CaCl 2 , and 1 mM MgCl 2 (pH 7.4). Homogenates were incubated on ice for 30 min and then were centrifuged at 300 g for 10 min. Supernatants were collected, were passed through a 0.45-mm filter, and were stored at Ϫ20ЊC for assay of cytokines.
VN assay. VN activity was assayed as reported elsewhere [14] . In brief, heat-inactivated serum samples were serially diluted in 96-well tissue culture plates (Costar), 4 wells per dilution, starting at a 3 log 2 (1:8) dilution in a 50-mL total volume of RPMI 1640 medium without serum. Influenza virus (A/Udorn or A/PR/8/34) at 200 TCID 50 in 50 mL of RPMI 1640 medium was added to each well. Control wells contained medium in place of immune serum or medium without virus. After incubation at room temperature (22ЊC) for 1 h, 50 mL of RPMI 1640 medium containing 3.75 mg/ mL of trypsin was added to each well. Then 150 mL from each well was transferred into wells containing 80% confluent monolayers of MDCK cells previously washed with PBS, and the plates were incubated at 35ЊC in a 5% CO 2 atmosphere. Three days later, we added 100 mL of 10% formalin. Plates were incubated for 1 h, and cells were washed with PBS and were stained with Coomassie brilliant blue for the determination of cytopathic effect. VN titers were calculated as the average of 4 dilutions per serum sample at which 100% virus neutralization occurred.
ELISA. The assay was done as described elsewhere [14] . In brief, 96-well MaxiSorp Nunc-Immuno plates (Nalgene Nunc International) were coated with whole virus purified by sucrose-gradient centrifugation, formalin-inactivated influenza vaccine, or rNP of influenza type A at 0.5 mg/mL. Serum antibodies were detected with horseradish peroxidase-conjugated anti-mouse immunoglobulin (Southern Biotechnology Associates).
Cytokine ELISAs. Cytokine levels in lung extracts were determined by a sensitive ELISA with capture and detection MAbs (PharMingen) specific for the murine cytokines, IFN-g, and interleukin (IL)-2, IL-4, IL-5, and IL-6. The cytokine ELISA was done as described elsewhere [29] . To determine the levels of cytokines present in test samples, 2-fold dilutions of recombinant (r) murine IL-4 (Endogen), rIL-5, rIL-6, rIFN-g (Genzyme), and rIL-2 (PharMingen) were used for the generation of standard curves, and values for the test samples then were interpolated. The actual values represent the mean of triplicate samples ‫1ע‬ SD. The detection limits (all in pg/mL) were 5 for IL-2, 25 for IFN-g, 20 for IL-4, 5 for IL-5, and 100 for IL-6.
Generation of antigen-specific CTL effector cells. Spleens and MLNs were harvested from 5 mice per group, and pooled singlecell suspensions were used for further analysis. A portion of the spleen cell suspension (stimulator cells) was infected with influenza virus A/Udorn at an MOI of 2-4 or with A/PR/8/34 at an MOI of 4-6 in a small volume (0.2 mL) of PBS or RPMI 1640 medium without FBS. After incubation for 30 min at 37ЊC in 5% CO 2 , RPMI 1640 complete medium was added, and the cell suspension was incubated for у3 h, irradiated (3000 rad), washed, and mixed with the remaining splenocytes (responder cells) at a ratio of 2:1 ( to responder cells/mL) in CTL complete medium 6 6 3 ϫ 10 4 ϫ 10 containing 10% FBS, 10 mM HEPES, 100 U/mL penicillin, 100 mg/mL streptomycin, 0.03% glutamine, and M 2-mer-
Ϫ5
3 ϫ 10 captoethanol. After murine rIL-2 (R&D Systems) was added to cultures at day 3 (20 U/mL), cultures were incubated another 3 days at 37ЊC in 5% CO 2 , and CTL effector cells were washed and tested with virus-infected major histocompatibility complex (MHC)-matched target cells in a 51 Cr release assay. Cr-labeled cells were washed 3 times. The cells were counted and were used as target cells in the cytotoxic assay, as described below. Preparation of epithelial CMT-93 target cells for cytotoxic assay was described elsewhere [30] . In brief, 1 week before the cytotoxic assay, confluent CMT-93 epithelial cell cultures were trypsinized and seeded in a 96-well flat-bottom microplate at cells per 100 mL/well. The 2 5 ϫ 10 cell density was 10 4 cells per well by 6 days in culture. These cell cultures were infected with Udorn or PR/8/34 at an MOI of 5 in 20 mL per well of medium without serum for 20 min at 37ЊC. The cells were washed free of unbound virus and were cultured overnight in 100 mL of complete medium containing 1 mCi of 51 Cr per well. Before cytotoxicity assessment, cell cultures in microplates were washed twice and were incubated with complete medium for 30 min before the last wash. The prepared epithelial CMT-93 cell cultures were used for target cells in the cytotoxic assay, as described below.
Cytotoxic assay. The 51 Cr-labeled EL-4 target cells were washed 3 times and were resuspended in complete medium at 10 5 cells/mL; 100-mL aliquots of the cell suspension were added to 96-well round-bottom microtiter plates containing triplicate 100-mL samples of serially diluted effector cells. In the assay with target epithelial cells, triplicate 100-mL samples of serially diluted effector cells were added to the microtiter plate with target CMT-93 epithelial cells [30] . The microtiter plates were centrifuged at 400 g for 5 min and then were incubated for 4 h at 37ЊC in 5% CO 2 . The level of released radioactivity in 100 mL of supernatant from each well was measured in a gamma counter (Cobra II Auto-Gamma; Packard Instrument). Specific lysis was calculated from the 51 Cr released in counts per minute (cpm) by using the formula: percentage specific lysis p [(experimental cpm Ϫ spontaneous release . Cpm for cpm)/(maximal cpm Ϫ spontaneous cpm)] ϫ 100 spontaneous and maximal release were determined by incubating target cells with either 100 mL of medium or 100 mL of 5% Triton X-100, respectively. Spontaneous release of 51 Cr in the absence of effector cells was usually !15% and did not exceed 20%. SE values were always !5% of the mean and therefore are not included.
Statistics. We express data as SE. All were compared mean ‫ע‬ 1 by 2-tailed Student's t test or by unpaired Mann-Whitney U test. Results were analyzed by the InStat 2.00 statistical program (GraphPad Software) for Macintosh computers.
was con-P ! .05 sidered statistically significant.
Results
Protection against lethal challenge with heterologous and homologous influenza viruses. The contribution of B and CD8
ϩ T cells in HSI was assessed by using m Ϫ/Ϫ and CD8 Ϫ/Ϫ mice, re- spectively. Although B cell-deficient mice are more susceptible to primary infection and to secondary challenge with homologous virus strain [22, 23] , in pilot experiments they recovered completely upon primary infection with virus strain A/Udorn (H3N2) at a sublethal dose. This dose was titrated to be sufficient to induce HSI in CD8 ϩ T cell-deficient and in immunocompetent mice. WT and gene knockout (KO) mice were immunized by TRT exposure to a sublethal dose of live A/Udorn (H3N2) virus. Four weeks later they were challenged with a lethal dose of mouse-adapted heterologous A/PR/8/34 (H1N1) virus or homologous A/Philippines (H3N2). Naive and immunized mice challenged with homologous virus served as controls for the HSI experiments. None of the m Ϫ/Ϫ mice, including homotypically immunized mice, survived the challenge (figure 1). In contrast, CD8
Ϫ/Ϫ and WT mice completely recovered from challenge (100%). The m Ϫ/Ϫ mice, but not CD8 Ϫ/Ϫ or WT mice, displayed severe weight loss starting at day 2 after challenge. Mortality was first observed as early as day 6 after challenge. A transient weight loss was observed in both groups of heterosubtypically immune CD8
Ϫ/Ϫ and WT mice (figure 2). No weight loss was seen in immunized WT or CD8 Ϫ/Ϫ mice challenged with homologous virus. This protection is presumably mediated by preexisting antibodies specific for homologous outer membrane glycoproteins. These results demonstrate that CD8 Ϫ/Ϫ and immunocompetent mice developed complete HSI against lethal challenge with influenza virus. In contrast, in the absence of B cells, mice had severe morbidity resulting in early mortality after challenge with heterologous virus.
Subtype cross-reactive CTL responses. Since m Ϫ/Ϫ mice have an intact T cell compartment, as confirmed by FACS analysis of T cell markers (data not shown), we examined whether subtype-specific CD8 ϩ CTL responses are induced in these mice. Four weeks after immunization, the mice were challenged with a lethal dose of A/PR/8/34 (H1N1) virus. On day 3 after challenge, 5 mice from each subgroup were assessed. Lymphocytes isolated from spleens and MLNs were subjected to 7-day in vitro culture for stimulation of antigen-specific CTL effector cells. Pronounced subtype-specific CTL responses were observed in spleens and MLNs of m Ϫ/Ϫ mice ( figure 3 ). When CD8 ϩ T cells were depleted from the effector cells by treating the cells with MAb specific for the CD8 molecule, before the cytotoxic assay was done, specific lysis was almost completely eliminated (data not shown). This result indicates that subtype-specific CTL activity is mediated predominantly by CD8 ϩ T cells. Thus, mice/group). n p 5 All assays were performed at multiple effector-to-target (E:T) ratios. the ability to mount subtype-specific CD8 ϩ CTL responses was intact in B cell-deficient mice. In contrast, mice lacking CD8 ϩ T cells failed to develop subtype-specific MHC class I-restricted CTL responses. The lack of CD8 ϩ T cells in these mice was confirmed by FACS analysis of effector cell populations isolated from MLNs and from spleens (data not shown). These CD8 Ϫ/Ϫ mice were completely protected when challenged with homologous or heterologous influenza virus strains. No correlation between subtype-specific CD8 ϩ CTL responses and HSI was observed in these mice.
One may ask whether the lack of lytic activity of one cell type could be compensated by the enhanced activity of other cell types. To address this, we analyzed MHC class II-restricted cytotoxic activity using CMT-93 expressing both MHC class I and class II [30] . Immunized CD8 Ϫ/Ϫ mice did not manifest CTL activity against virus-infected CMT-93 expressing MHC class II (figure 4). Antigen-specific CTL activity against EL-4 expressing MHC class I or CMT-93 expressing both MHC class I and class II target cells were seen in CD4 Ϫ/Ϫ mice and did not differ from those observed in immunocompetent mice. Thus, MHC class II-restricted cytotoxic activity mediated by non- ϩ T cells, the main component of cellular immunity. Pneumonia is the cause of death after influenza infection. Thus, cytokine expression in the lungs, the site of infection, reflects the role of the cytokines involved in the induction of HSI. Three days after challenge, lung extracts were analyzed for Th1-and Th2-type cytokine levels. The IL-4 levels were significantly elevated in B cell-but not in CD8 ϩ T cell-deficient mice ( , analysis of variance). However, no P ! .0001 statistically significant shift in other cytokines was observed in B cell-deficient or in CD8 ϩ T cell-deficient mice when compared with the profile observed in immunocompetent mice ( figure 5) . Furthermore, no correlation between the cytokine profile in the lungs and HSI could be made.
Humoral immune responses. Since VN activity is required for antibody-mediated virus clearance and since nonneutralizing antibodies that bind to virus-infected cells can reduce the production of progeny virus, as demonstrated in studies of primary influenza virus infection [25, 31] , the potential role of antibodies as mediators of HSI was considered. The dominant immune component involved in HSI is acquired immunity that requires memory responses. Memory T cells are a major source of IFNg in heterosubtypically immune mice, and IFN-g is crucial in the maturation of a humoral immune response [32, 33] . Therefore, we asked whether the lack of CD8 ϩ T cells and presumably the lack of IFN-g production impair the induction of VN and serotype cross-reactive antibodies. Mice were immunized by TRT exposure to live A/Udorn virus. One month later, serum samples Ϫ/Ϫ mice exhibited significant and comparable titers of VN antibodies specific for the immunizing but not the challenging virus (table 1) . This was also true for sera collected 3 days after the challenge with heterologous influenza virus. These results demonstrate that the induction of serum VN antibodies is not impaired in CD8 Ϫ/Ϫ mice. As in immunocompetent mice, CD8 Ϫ/Ϫ mice developed normal influenza-specific antibody responses as determined by ELISA titers of anti-NP antibodies ( ) ( figure 6 ). Thus, mice without CD8 ϩ T cells developed P p .579 normal VN and anti-NP antibody responses. As expected, no antibody response was detected in mice with targeted disruption in the immunoglobulin m heavy chain, and severely impaired antibody responses were also observed in CD4 Ϫ/Ϫ mice (figure 6; table 1).
Discussion
In this study, we determined the role of B cells and CD8 ϩ CTL responses as effectors in HSI against lethal influenza A infection using mice with targeted disruption in the immunoglobulin m heavy chain or in the a chain of the CD8 molecule. Our results demonstrate that B cell-deficient mice fail to develop complete HSI against lethal infection with influenza A virus, although subtype-specific CD8 ϩ CTL responses were fully induced in these mice. In contrast, CD8
ϩ T cell-deficient mice were completely protected against lethal challenge with heterologous virus. These mice developed normal antibody responses when compared with those induced in immunocompetent mice.
Cytokine analysis revealed that Th1-and Th2-type cytokine secretion in the lungs is not significantly altered in B cell-or in CD8
ϩ T cell-deficient mice. These results suggest that the immunologic impairment in B cell-or CD8 ϩ T cell-deficient mice is limited to the generation of humoral (B cell) or CTL (CD8 ϩ T cell) responses. It is well established that B cells are a source of a number of cytokines, including IL-12, that stimulate cytotoxic CD8 ϩ T cells [34, 35] , and CD8 ϩ T cells are a major source of IFN-g with potent effects on B cell stimulation and antibody secretion [32] . Nevertheless, a lack of B cells did not affect the induction of CD8 ϩ CTL responses, and conversely antibody responses were fully developed in the complete absence of CD8 ϩ T cells. The results are supported by previous findings that CD8 ϩ CTL responses were normally induced in B cell-deficient mice after primary influenza infection and challenge with homologous virus [22, 23, 36] . Up-regulation of IL-4 production in B cell-deficient mice upon challenge indicates that IL-4 may contribute a compensatory effect for the induction of CD8 ϩ CTL responses in these mice, since IL-4 is a prime inducer of CTL [37, 38] . Thus, B cell and CD8 ϩ T effector cell compartments are relatively separated with regard to their functions. These results also indicate that mice with targeted disruption of the IgM m chain or the a chain of the CD8 molecule are an excellent model for study of the role of individual effector immune responses in HSI.
The most important finding of this study is that B cells, but not subtype-specific CD8 ϩ CTL cells, are required for the development of complete HSI to lethal infection with influenza A virus. Furthermore, the lack of MHC class II-restricted cytotoxic activity in immunized CD8 Ϫ/Ϫ mice (figure 4) suggests that the HSI in these mice is unlikely to be due to compensatory CD4 ϩ CTL responses. Of interest, normal CTL activity was induced in CD4 Ϫ/Ϫ mice; however, these mice still developed an impaired HSI (figure 1), supporting the notion that CTL alone are not sufficient for complete HSI. These results are consistent with previous observations of HSI in b 2 -microglobulin-deficient mice that lack MHC class I-restricted, CD8
ϩ CTL-mediated cytotoxicity [17] [18] [19] 39 ], or T cell-depleted mice [19] . Although CD8 ϩ CTL can promote virus clearance and recovery in the absence of B cells, the efficiency is rather low since numerous subtype-specific cloned CD8 ϩ CTL were needed to clear infection caused by a much lower virus dose in B cell-deficient mice than the lethal dose used for challenge of immunocompetent mice [23] . In addition, in vivo depletion of CD8 ϩ T cells by MAbs led to partial, but not complete, elimination of HSI [16] . Although the depletion of CD8 ϩ T cells resulted in the death of B cell-deficient mice infected with a moderate dose of virus, this depletion had no effect on the mortality of immunocompetent mice [22] . Furthermore, CD8
ϩ T cell responses cleared infection with HKx31, a reassortant virus of relatively low pathogenicity, from the lungs of B cell-deficient mice [40] .
Although HSI has not been studied in B cell-deficient mice until recently, lack of B cells reduces immunity against primary infection with influenza virus [22, 23, 31, 41] . The important observation in our study is that B cell-deficient mice survived the primary infection with A/Udorn (H3N2) at the same dose that is used for the induction of HSI in immunocompetent mice. Furthermore, the primary infection evoked vigorous heterosubtypic CTL responses in B cell-deficient and in immunocompetent mice. The latter, but not B cell-deficient mice, developed HSI. Thus, whereas MHC I-restricted CD8 ϩ CTL are less efficient in HSI, B cells appear to be ultimately important for complete HSI.
In addition to the absence of HSI in B cell-deficient mice, severely impaired HSI along with lack of specific antibodies observed in CD4 ϩ T cell-deficient mice ( figure 1, figure 6 , and table 1, respectively) suggest a role for CD4 ϩ T cells in HSI. CD4 ϩ T cells alone are unable to clear virus and to promote recovery from primary infection [40, 42] , but they are important for providing help for B cells and antibody responses (reviewed in [43] ). Lack of specific antibodies is probably responsible for impaired HSI in CD4 ϩ T cell-deficient mice. In addition, in infected SCID mice, antibodies specific for viral internal proteins expressed on the surface of infected cells reduced production of progeny virus and inhibited the spread of the infection [25] , and VN activity is required for antibody-mediated virus clearance [31] . Thus, HSI is associated with functional B cells.
It is likely that early after challenge, preexisting subtype cross-reactive antibodies in heterosubtypically immune mice are the predominant effectors involved in limiting infection, whereas the later induction of VN antibodies is responsible for virus clearance and complete host recovery. Our results also indicate that in the absence of CD8 ϩ T cells, B cells may function alone to protect against challenge with heterologous virus strains. However, passive transfer of heterosubtypically immune serum protects against lethal infection with homologous, but not heterologous, strains of influenza type A [19] . This indicates that the role of subtype cross-reactive antibodies for HSI is not unambiguous, and additional factors along with subtype-spe-cific antibodies and subtype-specific CTL may play an important role in HSI. Of note, antibodies and other factors secreted by local MALT may be critical for HSI, since the immune responses observed in systemic lymphoid organs may not reflect the events occurring at the site of infection (i.e., the mucosal surface) [14] . The same observation is true for influenza virus as for other pathogens that initiate infection at the mucosal surface of the respiratory tract.
In conclusion, we found direct evidence that B cells, but not subtype-specific CD8 ϩ CTL, are necessary for the complete development of HSI to lethal infection with influenza A virus. Our results provide new insight into the effector mechanisms responsible for HSI. The effectiveness of either antibody-or CTL-mediated immune responses and possibly other additional host factors involved in HSI remain to be determined. Furthermore, although HSI is clearly important for the control of influenza infection in the murine model, its role in human disease is unclear.
